A Broad-Spectrum Antimicrobial Activity of Bacillus subtilis RLID 12.1
Figure 1
Inhibition zone produced by the test strain B. subtilis RLID 12.1. The figures 1, 2, and 3 in Plates (a) and (b) represent antibacterial activity against gram-negative bacteria: Pseudomonas sp. (clinical isolate), P. aeruginosa MTCC 2582, and E. coli MTCC 729, respectively; 4 represents inhibition against gram-positive bacteria, S. pyogenes MTCC 442. Figures 5, 6, and 7 in plates (c) and (d) represent antimycotic activity against C. neoformans NCIM 3378, C. glabrata MTCC 3019, and C. albicans DI (clinical isolate, GenBank accession number KJ095700), respectively.